Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wojciech Szeszkowski is active.

Publication


Featured researches published by Wojciech Szeszkowski.


Movement Disorders | 2008

MR spectroscopy in monitoring the treatment of Wilson's disease patients

Beata Tarnacka; Wojciech Szeszkowski; Marek Gołębiowski; Anna Członkowska

The aim of this study was to determine the effectiveness of brain proton magnetic resonance spectroscopy (1H‐MRS) for monitoring therapy in Wilsons disease (WD) patients. Voxels were located in the globus pallidus (right, left). We followed 17 newly diagnosed WD cases for 1‐year period. During this observation period, 6 neurological and 9 hepatic patients improved, while 2 neurological patients deteriorated. The pretreatment 1H‐MRS analysis showed a statistically significant lower level of mI/Cr, NAA/Cr, and higher Lip/Cr in all WD patients with improvement compared with controls. In patients with hepatic signs, a statistically significant increase of mI/Cr and Glx/Cr was observed in the second (1 year posttreatment) 1H‐MRS. In patients with neurological improvement after treatment in the follow‐up 1H‐MRS, a statistically significant increase of NAA/Cr was noted. During neurological deterioration, a decrease of Glx/Cr and NAA/Cr was seen, in contrast to another neurologically impaired patient with liver failure exacerbation, where a decrease of mI/Cr and increase of Glx/Cr was observed. The alternations of NAA/Cr ratio in neurologically impaired patients and mI/Cr and Glx/Cr in patients with liver failure could be a sensitive marker of the clinical recovery and deterioration in those WD patients. 1H‐MRS is a technique that can be used for accurate monitoring of treatment efficacy in WD patients.


Neurologia I Neurochirurgia Polska | 2011

Sex hormone patterns in women with multiple sclerosis as related to disease activity — a pilot study

Beata Zakrzewska-Pniewska; Marek Gołębiowski; Małgorzata Zajda; Wojciech Szeszkowski; Aleksandra Podlecka-Piętowska; Monika Nojszewska

BACKGROUND AND PURPOSE The influence of sex hormones on immune system activity in multiple sclerosis (MS) has been suggested by clinical evidence. The aim of the study was to ana-lyse the pattern of sex hormones in MS women and to correlate the hormone pattern abnormalities to the disease course as well as to the magnetic resonance imaging (MRI) results. MATERIAL AND METHODS We studied the serum level of the progesterone, β-oestradiol and prolactin in 46 women with clinical definite MS aged from 19 to 65; mean disease duration was 11.80 ± 9.86 years. The evaluation of the intensity of hormonal changes was done using a scoring system (0-3). On the brain MRI, the presence of brain atrophy, of hypothalamic demyelination as well as demyelination intensity (or degree) were analysed. The evaluation of the degree of demyelination and brain atrophy was done using a scoring system (0-4). RESULTS The main hormonal abnormalities consisted of decreased progesterone level, increased oestradiol level or both. The sex hormone pattern was abnormal in 56% of patients. Hypothalamic lesions were found on MRI in 53% of cases. The abnormal hormonal pattern correlated with intensity of MR changes (p < 0.05, Fishers exact test), but neither with presence of hypothalamic changes nor with disease parameters (Expanded Disability Status Scale, relapse rate, disease duration). CONCLUSIONS It is important to check the hormonal pattern in MS women because according to our results it may be related to the disease activity and probably affects the type of therapeutic intervention. This pilot study will be extended in a larger population.


Metabolic Brain Disease | 2009

Heterozygous carriers for Wilson's disease--magnetic spectroscopy changes in the brain.

Beata Tarnacka; Wojciech Szeszkowski; Janine Buettner; Marek Gołębiowski; Grażyna Gromadzka; Anna Członkowska

Wilson’s disease (WD) is an autosomal recessive disorder and the WD heterozygote carriers (Hzc) should not exhibit symptoms of the disease. The aim of this study was to assess 12 WD Hzc by brain Proton MR Spectroscopy. In three cases, the levels of caeruloplasmin, and in one case, serum copper, were below our normal range. In two Hzc the aspartate and alanine aminotransferase levels in the blood were slightly increased, however, no ultrasonographic liver changes were detected. The brain metabolite analysis showed a statistically significant higher mean ratio of Glx/Cr and Lip/Cr in MRS in Hzc in both the pallidum and thalami compared to control subjects. Our results suggest that WD Hzc may accumulate free copper in the basal ganglia.


BioMed Research International | 2016

Diffusion-Weighted Imaging of Small Peritoneal Implants in “Potentially” Early-Stage Ovarian Cancer

Laretta Grabowska-Derlatka; Paweł Derlatka; Wojciech Szeszkowski; Andrzej Cieszanowski

Introduction. MRI is established modality for the diagnosis of ovarian malignancies. Advances in MRI technology, including DW imaging, could lead to the further increase in the sensitivity of MRI for the detection of peritoneal metastases. The aim of this study was to assess the accuracy of DW imaging for detection of peritoneal metastatic disease in patients suspected of having potentially early ovarian cancer and secondly to evaluate ADC values of peritoneal implants. Materials and Methods. The prospective study group consisted of 26 women with sonographic or/and CT diagnosis of suspected ovarian tumor. Based on the results of the above imaging, in none of them was extraovarian spread of disease or ascites recognized. All patients underwent MRI with DW imaging. Results. Overall, 18 extraovarian peritoneal lesions were found on DW images in 10 from 26 examined patients. All implants had diameter ≤10 mm. The presence of all lesions diagnosed by MRI was confirmed intraoperatively. Histopathologic findings in 17 proofs confirmed ovarian cancer. PPV was 94%. On all DW images (with b values of 0, 50, 100, 150, 200, 400, 800, and 1200 s/mm2) the mean signal intensities of peritoneal lesions were significantly higher than the mean signal intensities of normal adjacent tissue (p = 0.000001).


Polish Journal of Radiology | 2016

Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC)

Andrzej Cieszanowski; Joanna Podgorska; Grzegorz Rosiak; Edyta Maj; Ireneusz P. Grudzinski; Bartosz Kaczynski; Wojciech Szeszkowski; Krzysztof Milczarek; Olgierd Rowiński

Summary Background To investigate the effect of gadoxetic acid disodium (Gd-EOB-DTPA) on T2 relaxation times and apparent diffusion coefficient (ADC) values of the liver and focal liver lesions on a 1.5-T system. Material/Methods Magnetic resonance (MR) studies of 50 patients with 35 liver lesions were retrospectively analyzed. All examinations were performed at 1.5T and included T2-weighted turbo spin-echo (TSE) and diffusion-weighted (DW) images acquired before and after intravenous administration of Gd-EOB-DTPA. To assess the effect of this hepatobiliary contrast agent on T2-weighted TSE images and DW images T2 relaxation times and ADC values of the liver and FLLs were calculated and compared pre- and post-injection. Results The mean T2 relaxation times of the liver and focal hepatic lesions were lower on enhanced than on unenhanced T2-weighted TSE images (decrease of 2.7% and 3.6% respectively), although these differences were not statistically significant. The mean ADC values of the liver showed statistically significant decrease (of 4.6%) on contrast-enhanced DW images, compared to unenhanced images (P>0.05). The mean ADC value of liver lesions was lower on enhanced than on unenhanced DW images, but this difference (of 2.9%) did not reach statistical significance. Conclusions The mean T2 relaxation times of the liver and focal liver lesions as well as the mean ADC values of liver lesions were not significantly different before and after administration of Gd-EOB-DTPA. Therefore, acquisition of T2-weighted and DW images between the dynamic contrast-enhanced examination and hepatobiliary phase is feasible and time-saving.


Polish Journal of Radiology | 2018

Magnetic resonance diffusion-weighted imaging in diagnostics of primary fallopian tube carcinoma – is it useful?

Laretta Grabowska-Derlatka; Wojciech Szeszkowski; Jacek Sienko; Paweł Derlatka

Purpose Primary fallopian tube carcinoma (PFTC) is the rarest form of female genital malignancy. The imaging applied for suspected adnexal masses includes transvaginal ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), but the vast majority of PFTC is recognised intraoperatively. Material and methods The study group consisted of seven women with postoperatively histopathological diagnosis of PFTC. To recognise characteristic findings for PFTC, retrospective analysis of preoperative MRI was performed. All patients underwent MRI of the pelvis and abdomen using a 1.5T MR system. Based on the results of the above imaging, suspected adnexal masses were recognised. MRI protocol contained T2-weighted images, fat-suppressed T2-weighted, T2-TIRM, DW EPI, pre- and postcontrast dynamic 3D T1 GRE in transverse orientation, with diffusion weightings of 0, 50, 100, 150, 200, 400, 800, and 1200 s/mm2. Regions of interest were outlined by a radiologist, who documented the character of adnexal masses on diffusion-weighted (DW) images and apparent diffusion coefficient (ADC) maps. Results In all seven patients with PFTC unilateral tumour was found. On all DW images (with β values of 0, 50, 100, 150, 200, 400, 800, and 1200 s/mm2) the mean signal intensities of solid parts of tumour were significantly higher than the mean signal intensities of normal ovarian tissue (p = 0.0001). There were no statistically significant differences between eight β values applied for ADC calculations. Conclusions Preoperative diagnostics of PFTC is difficult and mainly based on morphological features. Previous research did not show characteristics of PFTC in post-contrast dynamic imaging. In our material a clear increasing of signal intensity in DW imaging occurred independently of the β value.


European Radiology | 2002

Discrimination of benign from malignant hepatic lesions based on their T2-relaxation times calculated from moderately T2-weighted turbo SE sequence

Andrzej Cieszanowski; Wojciech Szeszkowski; Marek Gołębiowski; Dennis K. Bielecki; Mariusz Grodzicki; Bogdan Pruszynski


European Radiology | 2012

Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times

Andrzej Cieszanowski; Agnieszka Anysz-Grodzicka; Wojciech Szeszkowski; Bartosz Kaczynski; Edyta Maj; Barbara Górnicka; Mariusz Grodzicki; Ireneusz P. Grudzinski; Anna Stadnik; Marek Krawczyk; Olgierd Rowiński


Folia Neuropathologica | 2009

Spectral changes in postoperative MRS in high-grade gliomas and their effect on patient prognosis

Tomasz Czernicki; Wojciech Szeszkowski; Andrzej Marchel; Marek Gołębiowski


Metabolic Brain Disease | 2010

Brain proton magnetic spectroscopy in long-term treatment of Wilson’s disease patients

Beata Tarnacka; Wojciech Szeszkowski; Marek Gołębiowski; Anna Członkowska

Collaboration


Dive into the Wojciech Szeszkowski's collaboration.

Top Co-Authors

Avatar

Marek Gołębiowski

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Andrzej Cieszanowski

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Piotr Palczewski

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Edyta Maj

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Olgierd Rowiński

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Anna Członkowska

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Andrzej Marchel

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar

Bartosz Kaczynski

Medical University of Warsaw

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge